Alliance Foundation Trials, Llc.
Clinical trials sponsored by Alliance Foundation Trials, Llc., explained in plain language.
-
New hope for small cell lung cancer: immunotherapy after surgery
Disease control Recruiting nowThis phase 2 trial tests whether adding the immunotherapy drug durvalumab to standard chemotherapy after surgery can help prevent small cell lung cancer from coming back. About 65 adults who had their cancer completely removed will receive the combination for 12 weeks, then durva…
Phase: PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New hope for recurrent endometrial cancer: personalized combo therapy tested
Disease control Recruiting nowThis study tests whether combining targeted drugs with the immunotherapy atezolizumab can shrink tumors or slow cancer growth in people with endometrial cancer that has come back or persists. About 148 participants whose cancer has progressed after at least one prior treatment wi…
Phase: PHASE1, PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Money stress and cancer: new study tests if monthly screening eases the burden
Symptom relief Recruiting nowThis study looks at whether asking people with advanced cancer about their financial struggles each month can help reduce their worry and improve their quality of life. About 1,000 adults receiving treatment for advanced or metastatic cancer will be randomly assigned to either mo…
Phase: NA • Sponsor: Alliance Foundation Trials, LLC. • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC